Point-of-Care Technologies for the Advancement of Precision Medicine in Heart, Lung, Blood, and Sleep Disorders
| Autor: | Brian Jamieson, Jue Chen, Kyeong-Sik Shin, Tony Jun Huang, Yufei Mao, Erin Iturriaga, Po-Hsun Huang, Mary Emma Gorham Bigelow, Bishow B. Adhikari, Chi On Chui, Liqiang Ren |
|---|---|
| Jazyk: | angličtina |
| Rok vydání: | 2016 |
| Předmět: |
Request for Applications
medicine.medical_specialty lcsh:Medical technology Emerging technologies precision medicine Biomedical Engineering 030204 cardiovascular system & hematology lcsh:Computer applications to medicine. Medical informatics Commercialization Article 03 medical and health sciences 0302 clinical medicine Time of day Health care medicine 030212 general & internal medicine point-of-care technologies Intensive care medicine commercialization Point of care business.industry General Medicine Precision medicine 3. Good health lcsh:R855-855.5 lcsh:R858-859.7 Sleep (system call) business Biosensor |
| Zdroj: | IEEE Journal of Translational Engineering in Health and Medicine, Vol 4, Pp 1-10 (2016) IEEE Journal of Translational Engineering in Health and Medicine |
| ISSN: | 2168-2372 |
| Popis: | The commercialization of new point of care technologies holds great potential in facilitating and advancing precision medicine in heart, lung, blood, and sleep (HLBS) disorders. The delivery of individually tailored health care to a patient depends on how well that patient’s health condition can be interrogated and monitored. Point of care technologies may enable access to rapid and cost-effective interrogation of a patient’s health condition in near real time. Currently, physiological data are largely limited to single-time-point collection at the hospital or clinic, whereas critical information on some conditions must be collected in the home, when symptoms occur, or at regular intervals over time. A variety of HLBS disorders are highly dependent on transient variables, such as patient activity level, environment, time of day, and so on. Consequently, the National Heart Lung and Blood Institute sponsored a request for applications to support the development and commercialization of novel point-of-care technologies through small businesses (RFA-HL-14-011 and RFA-HL-14-017). Three of the supported research projects are described to highlight particular point-of-care needs for HLBS disorders and the breadth of emerging technologies. While significant obstacles remain to the commercialization of such technologies, these advancements will be required to achieve precision medicine. A discussion of the importance of point-of-care (POC) technologies in facilitating precision medicine for heart, lung, blood, and sleep disorders, including three such technologies currently undergoing commercialization. |
| Databáze: | OpenAIRE |
| Externí odkaz: |
|